These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 18200060)
1. PTPN22 is genetically associated with risk of generalized vitiligo, but CTLA4 is not. LaBerge GS; Bennett DC; Fain PR; Spritz RA J Invest Dermatol; 2008 Jul; 128(7):1757-62. PubMed ID: 18200060 [TBL] [Abstract][Full Text] [Related]
2. CTLA4 and generalized vitiligo: two genetic association studies and a meta-analysis of published data. Birlea SA; Laberge GS; Procopciuc LM; Fain PR; Spritz RA Pigment Cell Melanoma Res; 2009 Apr; 22(2):230-4. PubMed ID: 19175525 [TBL] [Abstract][Full Text] [Related]
3. The PTPN22-1858C>T (R620W) functional polymorphism is associated with generalized vitiligo in the Romanian population. Laberge GS; Birlea SA; Fain PR; Spritz RA Pigment Cell Melanoma Res; 2008 Apr; 21(2):206-8. PubMed ID: 18426414 [TBL] [Abstract][Full Text] [Related]
4. Association analysis of PTPN22, CTLA4 and IFIH1 genes with type 1 diabetes in Colombian families. Rodríguez A; Alfaro JM; Balthazar V; Pineda Trujillo N J Diabetes; 2015 May; 7(3):402-10. PubMed ID: 25042601 [TBL] [Abstract][Full Text] [Related]
5. Confirmation of the genetic association of CTLA4 and PTPN22 with ANCA-associated vasculitis. Carr EJ; Niederer HA; Williams J; Harper L; Watts RA; Lyons PA; Smith KG BMC Med Genet; 2009 Dec; 10():121. PubMed ID: 19951419 [TBL] [Abstract][Full Text] [Related]
6. Autoimmunity-Related Risk Variants in PTPN22 and CTLA4 Are Associated With ME/CFS With Infectious Onset. Steiner S; Becker SC; Hartwig J; Sotzny F; Lorenz S; Bauer S; Löbel M; Stittrich AB; Grabowski P; Scheibenbogen C Front Immunol; 2020; 11():578. PubMed ID: 32328064 [TBL] [Abstract][Full Text] [Related]
7. Genetic variations in NALP1 are associated with generalized vitiligo in a Romanian population. Jin Y; Birlea SA; Fain PR; Spritz RA J Invest Dermatol; 2007 Nov; 127(11):2558-62. PubMed ID: 17637824 [TBL] [Abstract][Full Text] [Related]
8. Associations of single nucleotide polymorphisms of PTPN22 and Ctla4 genes with the risk of allergic rhinitis in a Chinese Han population. Ke X; Song S; Wang X; Shen Y; Kang H; Hong S Hum Immunol; 2017 Feb; 78(2):227-231. PubMed ID: 27888068 [TBL] [Abstract][Full Text] [Related]
9. A single-nucleotide polymorphism in the gene encoding lymphoid protein tyrosine phosphatase (PTPN22) confers susceptibility to generalised vitiligo. Cantón I; Akhtar S; Gavalas NG; Gawkrodger DJ; Blomhoff A; Watson PF; Weetman AP; Kemp EH Genes Immun; 2005 Oct; 6(7):584-7. PubMed ID: 16015369 [TBL] [Abstract][Full Text] [Related]
10. Autoimmunity in primary antibody deficiency is associated with protein tyrosine phosphatase nonreceptor type 22 (PTPN22). Chew GY; Sinha U; Gatenby PA; DeMalmanche T; Adelstein S; Garsia R; Hissaria P; French MA; Wilson A; Whittle B; Kirkpatrick P; Riminton DS; Fulcher DA; Cook MC J Allergy Clin Immunol; 2013 Apr; 131(4):1130-5, 1135.e1. PubMed ID: 22857794 [TBL] [Abstract][Full Text] [Related]
11. Genetic variant association of PTPN22, CTLA4, IL2RA, as well as HLA frequencies in susceptibility to alopecia areata. Moravvej H; Tabatabaei-Panah PS; Abgoon R; Khaksar L; Sokhandan M; Tarshaei S; Ghaderian SMH; Ludwig RJ; Akbarzadeh R Immunol Invest; 2018 Oct; 47(7):666-679. PubMed ID: 29979892 [TBL] [Abstract][Full Text] [Related]
12. Genotype analysis of polymorphisms in autoimmune susceptibility genes, CTLA-4 and PTPN22, in an acute anterior uveitis cohort. Martin TM; Bye L; Modi N; Stanford MR; Vaughan R; Smith JR; Wade NK; Mackensen F; Suhler EB; Rosenbaum JT; Wallace GR Mol Vis; 2009; 15():208-12. PubMed ID: 19180256 [TBL] [Abstract][Full Text] [Related]
13. Protein tyrosine phosphatase PTPN22 in human autoimmunity. Vang T; Miletic AV; Bottini N; Mustelin T Autoimmunity; 2007 Sep; 40(6):453-61. PubMed ID: 17729039 [TBL] [Abstract][Full Text] [Related]
14. Clinical associations of the genetic variants of CTLA-4, Tg, TSHR, PTPN22, PTPN12 and FCRL3 in patients with Graves' disease. Gu LQ; Zhu W; Zhao SX; Zhao L; Zhang MJ; Cui B; Song HD; Ning G; Zhao YJ Clin Endocrinol (Oxf); 2010 Feb; 72(2):248-55. PubMed ID: 19438904 [TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and PTPN22 1858C/T variant analysis in Jordanian Arab vitiligo patients. Alkhateeb A; Qarqaz F; Al-Sabah J; Al Rashaideh T Mol Diagn Ther; 2010 Jun; 14(3):179-84. PubMed ID: 20560680 [TBL] [Abstract][Full Text] [Related]
16. The CTLA-4 +49 A/G, CT60 A/G and PTPN22 1858 C/T polymorphisms and susceptibility to vitiligo: a meta-analysis. Song GG; Kim JH; Lee YH Mol Biol Rep; 2013 Apr; 40(4):2985-93. PubMed ID: 23264102 [TBL] [Abstract][Full Text] [Related]
17. Identification of susceptibility SNPs in CTLA-4 and PTPN22 for scleritis in Han Chinese. Li F; Ma X; Du L; Shi L; Cao Q; Li N; Pang T; Liu Y; Kijlstra A; Yang P Clin Exp Immunol; 2019 Aug; 197(2):230-236. PubMed ID: 30921471 [TBL] [Abstract][Full Text] [Related]
18. PTPN22 and CTLA-4 Polymorphisms Are Associated With Polyglandular Autoimmunity. Houcken J; Degenhart C; Bender K; König J; Frommer L; Kahaly GJ J Clin Endocrinol Metab; 2018 May; 103(5):1977-1984. PubMed ID: 29409002 [TBL] [Abstract][Full Text] [Related]
19. The +1858C/T PTPN22 gene polymorphism confers genetic susceptibility to rheumatoid arthritis in Mexican population from the Western Mexico. Torres-Carrillo NM; Ruiz-Noa Y; Martínez-Bonilla GE; Leyva-Torres SD; Torres-Carrillo N; Palafox-Sánchez CA; Navarro-Hernández RE; Rangel-Villalobos H; Oregón-Romero E; Muñoz-Valle JF Immunol Lett; 2012 Sep; 147(1-2):41-6. PubMed ID: 22743847 [TBL] [Abstract][Full Text] [Related]
20. Transethnic associations among immune-mediated diseases and single-nucleotide polymorphisms of the aryl hydrocarbon response gene ARNT and the PTPN22 immune regulatory gene. Schurman SH; O'Hanlon TP; McGrath JA; Gruzdev A; Bektas A; Xu H; Garantziotis S; Zeldin DC; Miller FW J Autoimmun; 2020 Feb; 107():102363. PubMed ID: 31759816 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]